| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 4, 2010Educational Campaign Encourages Women to Seek Support for Bladder Control Issues
MINNEAPOLIS, Nov 04, 2010 (BUSINESS WIRE) -- In support of Bladder Health Awareness Month and the struggles 33 million Americans face year-round with bladder control issues, Medtronic, Inc. (NYSE:...
-
Nov 1, 2010New Tip Capture Feature Enables Controlled Deployment and Precise Placement of Stent Graft During Minimally Invasive Procedure to Repair Body's Main Artery
MINNEAPOLIS, Nov 01, 2010 (BUSINESS WIRE) -- Advancing the minimally invasive treatment of aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced approval by the U.S. Food and Drug...
-
Nov 1, 2010
MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT), the leader in spinal cord stimulation for more than 25 years, today announced U.S. Food and Drug Administration (FDA)...
-
Oct 29, 2010
MINNEAPOLIS, Oct 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the...
-
Oct 21, 2010Kyphon Xpander(TM) II Inflatable Bone Tamp Is Latest Innovation in Minimally Invasive Treatment of Spinal Fractures
MINNEAPOLIS, Oct 21, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced Food and Drug Administration (FDA) clearance of the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the...
-
Oct 15, 2010Investigational Transcatheter Aortic Valve Implantation System Part of Medtronic's Growing Portfolio for U.S. Patients with Severe Aortic Stenosis
MINNEAPOLIS, Oct 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE)...
-
Oct 14, 2010
MINNEAPOLIS, Oct 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that it has entered into an agreement to settle existing U.S. lawsuits relating to its Sprint Fidelis(R)...
-
Oct 13, 2010First-Ever Spinal Fracture Awareness Walk and Health Fair Set for Nov. 14, 2010
SAN FRANCISCO, Oct 13, 2010 (BUSINESS WIRE) -- To increase awareness of the debilitating effects of spinal fractures and the symptoms, causes and available treatments, American Bone Health;...
-
Oct 6, 2010
MEMPHIS, Tenn., Oct 06, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of the VERTEX SELECT(R) Reconstruction System Posted Screw Module. The announcement was...
-
Oct 5, 2010Extraordinary Runners from Around the World Complete Medtronic Twin Cities Marathon Events with Help from Medical Technology
MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Twenty-four Medtronic Global Heroes, long-distance runners who benefit from medical technology, successfully completed either the Medtronic Twin Cities...
-
Oct 5, 2010
MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced the launch of the new KYPHON(R) Express(TM) Curette for scraping or scoring bone in the spine, including...
-
Oct 1, 2010
MINNEAPOLIS, Oct 01, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Twin Cities In Motion (formerly Twin Cities Marathon, Inc.) announced they have signed a letter of intent to continue...
-
Sep 28, 2010Reveal(R) Plus Study Results Published Today in Circulation
MINNEAPOLIS, Sep 28, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of results from a multicenter, prospective study that demonstrated that the company's Reveal(R)
-
Sep 28, 2010Data from 1,500-Patient IN.PACT(TM) Clinical Program Presented at TCT; First Patient Enrolled in European Study on Device's Use in SFA Disease
WASHINGTON, Sep 28, 2010 (BUSINESS WIRE) -- Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc. (NYSE: MDT), today announced...
-
Sep 23, 2010Announced at Clinton Global Initiative, an initial $1 million in grants are part of an overall strategic effort to reduce the burden of chronic disease
MINNEAPOLIS, Sep 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. today announced at the Clinton Global Initiative a $1 million commitment to the NCD Alliance. The grants are made in preparation for...
-
Sep 20, 2010Superior Deliverability Distinguishes New Medical Device Based on Engineering Advance of Continuous Sinusoid Technology
MINNEAPOLIS, Sep 20, 2010 (BUSINESS WIRE) -- Delivering another innovation for interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA)...
-
Sep 20, 2010Consistent Results in More Than 3,600 Patients from Complex Daily Practice of Interventional Cardiology Strengthen Evidence on Implantable Heart Device
WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...
-
Sep 17, 2010Initial Results Suggest ONS Warrants Further Study for Control of Chronic Migraine
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise...
-
Sep 17, 2010Interventional Cardiology Meeting Features New Data on Resolute(R) Drug-Eluting Stent, IN.PACT(TM) Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...
-
Sep 16, 2010Further Clinical Study Required for Application to U.S. Food and Drug Administration
MINNEAPOLIS, Sep 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain...
-
Sep 14, 2010
MINNEAPOLIS, Sep 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the UBS Global Life Sciences...
-
Sep 13, 2010System Supports Proactive Patient Care for Patients at Risk for Worsening Heart Failure
MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced the CareLink(R) Network for Heart Failure, an extension of the world's largest remote implantable cardiac...
-
Sep 13, 2010Medical Device Leader Recognized for Corporate Sustainability
MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
-
Sep 10, 2010"Innovating for a Better World" Reviews Company's Economic, Social and Environmental Performance for Fiscal Year 2010
MINNEAPOLIS, Sep 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) has released "Innovating for a Better World," the company's 2010 Corporate Citizenship Report. The online report, which...
-
Sep 7, 2010
Resolute Integrity Stent Launched in the UK Medtronic, Inc. (NYSE: MDT), announces the CE (Conformite Europeene) mark and international launch of the Resolute Integrity Stent System for the...